Epigenomic exploration of disease status of EGFR-mutated non-small cell lung cancer using plasma cell-free DNA hydroxymethylomes

Yong Peng, Jason Karpus, Jyoti D. Patel, Everett E. Vokes, Marina Chiara Garassino, Kirsteen Lugtu, Zhou Zhang, Wei Zhang, Mengjie Chen, Chuan He, Christine M. Bestvina

Cancer Communications ›› 2025, Vol. 45 ›› Issue (01) : 51-55.

PDF
Cancer Communications ›› 2025, Vol. 45 ›› Issue (01) : 51-55. DOI: 10.1002/cac2.12606
LETTER TO THE JOURNAL

Epigenomic exploration of disease status of EGFR-mutated non-small cell lung cancer using plasma cell-free DNA hydroxymethylomes

Author information +
History +

Cite this article

Download citation ▾
Yong Peng, Jason Karpus, Jyoti D. Patel, Everett E. Vokes, Marina Chiara Garassino, Kirsteen Lugtu, Zhou Zhang, Wei Zhang, Mengjie Chen, Chuan He, Christine M. Bestvina. Epigenomic exploration of disease status of EGFR-mutated non-small cell lung cancer using plasma cell-free DNA hydroxymethylomes. Cancer Communications, 2025, 45(01): 51‒55 https://doi.org/10.1002/cac2.12606

References

[1]
Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021; 398(10299): 535-54.
CrossRef Google scholar
[2]
Zhang YL, Yuan JQ, Wang KF, Fu XH, Han XR, Threapleton D, et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 2016; 7(48): 78985-93.
CrossRef Google scholar
[3]
Beadell AV, Zhang Z, Capuano AW, Bennett DA, He C, Zhang W, et al. Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer’s Disease. J Alzheimers Dis. 2023; 93(3): 1135-51.
CrossRef Google scholar
[4]
Guler GD, Ning Y, Ku CJ, Phillips T, McCarthy E, Ellison CK, et al. Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA. Nat Commun. 2020; 11(1): 5270.
CrossRef Google scholar
[5]
Cao S, Feng H, Yi H, Pan M, Lin L, Zhang YS, et al. Single-cell RNA sequencing reveals the developmental program underlying proximal-distal patterning of the human lung at the embryonic stage. Cell Res. 2023: 1-13.
[6]
Yuan C, Hu H, Kuang M, Chen Z, Tao X, Fang S, et al. Super enhancer associated RAI14 is a new potential biomarker in lung adenocarcinoma. Oncotarget. 2017; 8(62): 105251-61.
CrossRef Google scholar
[7]
Jiang Z, Zhao J, Zou H, Cai K. CircRNA PTPRM Promotes Non-Small Cell Lung Cancer Progression by Modulating the miR-139-5p/SETD5 Axis. Technol Cancer Res Treat. 2022; 21: 15330338221090090.
CrossRef Google scholar
[8]
Unsal M, Kara N, Karakus N, Tural S, Elbistan M. Effects of leptin and leptin receptor gene polymorphisms on lung cancer. Tumour Biol. 2014; 35(10): 10231-6.
CrossRef Google scholar
[9]
Zhou J, Lin Y, Kang X, Liu Z, Zou J, Xu F. Hypoxia-mediated promotion of glucose metabolism in non-small cell lung cancer correlates with activation of the EZH2/FBXL7/PFKFB4 axis. Cell Death Dis. 2023; 14(5): 326.
CrossRef Google scholar

RIGHTS & PERMISSIONS

2024 2024 The Author(s). Cancer Communications published by John Wiley & Sons Australia, Ltd on behalf of Sun Yat-sen University Cancer Center.
PDF

Accesses

Citations

Detail

Sections
Recommended

/